Sagar Lonial - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Sagar Lonial has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $824K.
Profile
Sagar Lonial is Director at TG THERAPEUTICS, INC. (TGTX). Lonial has reported 4 insider filings with the SEC since 2024. The most recent filing was in June 2026.
| Role | Director |
|---|---|
| Notability | 26/100 |
Board memberships
- TG THERAPEUTICS, INC.
Reported roles
- Director
Trading Pattern
InsiderAlpha's records for Sagar Lonial go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Sagar Lonial has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at TG THERAPEUTICS, INC. (TGTX) - 4 filings, 2024 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-11 | TGTX | TG THERAPEUTICS, INC. | S - Open-market sale | 20.9K | $32.24 | $672K |
| 2025-06-12 | TGTX | TG THERAPEUTICS, INC. | A - Grant or award | 14.7K | $0.00 | |
| 2024-11-12 | TGTX | TG THERAPEUTICS, INC. | S - Open-market sale | 5.0K | $30.44 | $152K |
Companies - Last 90 Days
- TG THERAPEUTICS, INC. (TGTX) - 1 filing, last 2026-06-15
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Sagar Lonial has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Yann Echelard - $163K of TGTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Nicholas S. Schorsch
- Trygve Seglem
- Lawrence B. Seidman
- Thomas J. Shaw
- Silver Point Capital L.P.
- SilverBay Capital Management LLC
- Michael Simanovsky
- Bob R. Simpson
Frequently Asked Questions
Who is Sagar Lonial?
Sagar Lonial is Director at TG THERAPEUTICS, INC. (TGTX). Lonial has reported 4 insider filings with the SEC since 2024. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Sagar Lonial submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sagar Lonial been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($824K) across all tracked filings.
Where can I see all of Sagar Lonial's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Sagar Lonial profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.